John Kuriyan

Crucial research by Neil Osheroff and his lab led to FDA approval of the first new class of antibacterial drugs in decades. The drug, gepotidacin, developed by GlaxoSmithKline under the brand name Blujepa, is now approved to treat uncomplicated urinary tract infections and gonorrhea. Read More

After a rigorous nomination and review process, Lisa M. Monteggia and Matthew J. Tyska are among the 471 scientists elected as 2024 fellows of the American Association for the Advancement of Science. Dean of School of Medicine Basic Sciences John Kuriyan was also recently elected a member of the 2025 class of fellows of the American Association for Cancer Research academy. Read More

Vanderbilt’s Carrie K. Jones and the University of Glasgow’s Andrew Tobin have received a prestigious £5 million ($6.2 million) Wellcome Trust Discovery Award to study how blocking the M5 muscarinic receptor in the brain could reduce opioid addiction while preserving pain relief. This groundbreaking international collaboration, supported by the Warren Center for Neuroscience Drug Discovery, aims to advance new treatments in the critical global health crisis of opioid use disorder. Read More

Vanderbilt University’s new Center for Computational Systems Biology brings computer science, engineering and biomedical researchers together with clinicians at Vanderbilt University Medical Center to accelerate discovery related to human diseases and conditions. Read More

Researchers at the Warren Center for Neuroscience Drug Discovery have detailed the successful drug discovery of a Phase I Single Ascending Dose clinical trial of VU319, a drug for memory loss in people with Alzheimer’s disease and schizophrenia. Read More

Doug Mitchell has been appointed the holder of the William Kelly Warren Sr. Chair in Biochemistry and professor of chemistry and director of the Vanderbilt Institute for Chemical Biology. Read More

Researchers at the Warren Center for Neuroscience Drug Discovery, a clinical stage biotech within the Vanderbilt University School of Medicine Basic Sciences, have detailed the successful drug discovery of a Phase I Single Ascending Dose clinical trial of VU319, a drug for memory loss in people with Alzheimer’s disease and schizophrenia. Read More

Researchers at the Warren Center for Neuroscience Drug Discovery, a clinical stage biotech within the Vanderbilt University School of Medicine Basic Sciences, have detailed the successful drug discovery of a Phase I Single Ascending Dose clinical trial of VU319, a drug for memory loss in people with Alzheimer’s disease and schizophrenia. Read More

For John Jumper, BS’07, the road to winning the Nobel Prize in chemistry began with an interdisciplinary education at Vanderbilt.  Read More

The group will build upon existing work to leverage Vanderbilt-driven research and innovation to support local community needs, attract entrepreneurial talent and venture investment, and expand our city and region’s innovation capacity. They also will examine infrastructure needs, including dedicated physical space, programs for collaboration and how to foster a culture of innovation.  Read More

After a rigorous nomination and review process, Vanderbilt University professors -- Jada Benn Torres, David Cliffel, Volker Haase, Janet Macdonald, Xiao-Ou Shu, Keith Wilson and Zheng Wei -- were named fellows of the American Association for the Advancement of Science. Read More

The distinguished faculty members and deans representing eight colleges and schools were presented with medallions that symbolize the attainment of their positions and will become part of their official academic regalia. Chair holders contribute their expertise to real-world challenges, including climate change, political inequality and access to justice, artificial intelligence and ICU trauma.   Read More

An $8.9 million grant from the NIH will establish the Vanderbilt AUD Research and Education Center, enhancing Vanderbilt University’s national leadership in neuroscience and addiction research. This initiative aims to foster interdisciplinary collaboration, advance understanding and treatment of alcohol use disorder, and engage the public through education and outreach efforts. Read More

Combining deep mutagenesis and cryo-EM reveals new conformational state of a protein responsible for high-speed DNA replication. The research builds on growing theories of molecular evolution. Read More

The School of Medicine Basic Sciences and the Office of the Vice Provost for Research and Innovation launch the Innovation Ignition Fund. This pilot program offers up to $500,000 in funding and drug development mentorship from Vanderbilt scientists with expertise in translational research. Read More

Vanderbilt has announced the addition of the Warren Center for Neuroscience Drug Discovery into Discovery Vanderbilt as well as an initiative within the Dare to Grow campaign to inspire philanthropy with a one-to-one match for gifts of $100,000 or more. Read More

10 basic sciences graduate students were recognized for their high academic and scientific achievement and for the originality, significance, and rigor of their dissertation research with the Dean’s Award for Exceptional Achievement in Graduate Studies. Read More